Guangdong Biolight Meditech Co., Ltd. Stock
Equities
300246
CNE1000015Q4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.19 CNY | -0.69% | -3.23% | -30.19% |
Sales 2022 | 1.18B 164M | Sales 2023 | 1.19B 165M | Capitalization | 2.73B 377M |
---|---|---|---|---|---|
Net income 2022 | 22M 3.05M | Net income 2023 | -65M -9M | EV / Sales 2022 | 2.13 x |
Net cash position 2022 | 352M 48.77M | Net cash position 2023 | 236M 32.67M | EV / Sales 2023 | 2.08 x |
P/E ratio 2022 |
128
x | P/E ratio 2023 |
-41.7
x | Employees | 1,419 |
Yield 2022 |
1.23% | Yield 2023 |
-
| Free-Float | 66.58% |
1 day | -0.69% | ||
1 week | -3.23% | ||
Current month | +4.66% | ||
1 month | +13.41% | ||
3 months | +19.04% | ||
6 months | -36.60% | ||
Current year | -30.19% |
Managers | Title | Age | Since |
---|---|---|---|
Jin Yuan Yan
CEO | Chief Executive Officer | 61 | 08-01-19 |
Wei Wei Xu
DFI | Director of Finance/CFO | 49 | 22-12-25 |
Jin Liang
CTO | Chief Tech/Sci/R&D Officer | 50 | 13-12-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jun Dong Xue
BRD | Director/Board Member | 52 | 21-07-04 |
Jin Yuan Yan
CEO | Chief Executive Officer | 61 | 08-01-19 |
Jin Liang
CTO | Chief Tech/Sci/R&D Officer | 50 | 13-12-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 7.19 | -0.69% | 5,854,691 |
24-05-16 | 7.24 | -1.23% | 7,110,540 |
24-05-15 | 7.33 | +1.10% | 6,021,456 |
24-05-14 | 7.25 | +0.42% | 8,228,635 |
24-05-13 | 7.22 | -2.83% | 10,344,910 |
End-of-day quote Shenzhen S.E., May 16, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.19% | 262M | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- 300246 Stock